Rene Bernards's most recent trade in Lixte Biotechnology Holdings Inc was a trade of 10,662 Options to Purchase Common Stock done . Disclosure was reported to the exchange on June 30, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lixte biotech Holdings Inc | Rene Bernards | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2025 | 10,662 | 10,662 | - | - | Options to Purchase Common Stock | |
| Lixte biotech Holdings Inc | Rene Bernards | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2025 | 10,000 | 10,000 | - | - | Options to Purchase Common Stock | |
| Lixte biotech Holdings Inc | Rene Bernards | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 8,045 | 8,045 | - | - | Options to Purchase Common Stock | |
| Lixte biotech Holdings Inc | Rene Bernards | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2025 | 4,166 | 4,166 | - | - | Options to Purchase Common Stock | |
| Lixte biotech Holdings Inc | Rene Bernards | Director | 30 Sep 2024 | 5,304 | 5,304 | - | - | Options to Purchase Common Stock | ||
| Lixte biotech Holdings Inc | Rene Bernards | Director | 30 Jun 2024 | 10,000 | 10,000 | - | - | Options to Purchase Common Stock | ||
| Lixte biotech Holdings Inc | Rene Bernards | Director | 30 Jun 2024 | 4,149 | 4,149 | - | - | Options to Purchase Common Stock | ||
| Lixte biotech Holdings Inc | Rene Bernards | Director | 12 Dec 2022 | 10,000 | 135,000 | - | 0.6 | 6,100 | Common Stock | |
| Lixte biotech Holdings Inc | Rene Bernards | Director | 14 Nov 2022 | 52,500 | 125,000 | - | 0.5 | 27,825 | Common Stock |